main biocides

Biocides

Biocidal products are regulated in the European Union by the Biocidal Product Regulation 528/2012 (BPR). The BPR requires rigorous evaluation of biocidal active substances and biocidal products, ensuring that by placing a product on the market no unacceptable risk is posed to human health, animals or the environment. Examples of biocidal products include: antifouling products, disinfectants, rodenticides, insecticides, slimicides, fungicides and preservatives.

Enviresearch supports both active substance submissions and biocidal product authorisations across the EU. We have the regulatory and scientific expertise to ensure your business stays compliant with EU biocide legislation for your new and existing products.

Our services include:
  • Regulatory advice and support
  • Data gap analysis and data filling strategies
  • Preparation of active substance and product dossiers using IUCLID software
  • Submission and management of dossiers using the IT platform R4BP
  • Human health and environmental risk assessment:
    • Hazard assessment and QSARs for active substances and substances of concern
    • Definition of exposure scenarios, e.g. using BPD technical notes for guidance (TNsG), and ECHA exposure scenario documents (ESD)
    • Environmental fate modelling (e.g. using EUSES)
    • Higher-tier assessments
  • Experience with biocidal product families (meta groups)
  • Planning and management of efficacy trials
  • Design and management of toxicity testing programs
  • Technical equivalence assessments
  • Preparation of waivers
  • Assessment of data requirements for active substance approval
  • Review, evaluate and perform completeness checks on efficacy, environmental toxicology, product chemistry, analytical chemistry and environmental fate data

 

Enviresearch logo

 

Contact

Enviresearch Ltd
34 Grainger Park Road
Newcastle upon Tyne NE4 8RY

Telephone: +44 (0)191 243 0687
Fax: +44 (0)191 222 3528
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Further Information

Subscribe

Please enter your email address

Invalid Input